ELLE DYSON: Open Payments
NPI 1255912127 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 67 payments from 14 companies in 2025. Trend: 2023 $768 · 2024 $1,710 · 2025 $1,640
Food & beverage: $861Consulting: $410Education: $369
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 15 | $733 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $220 |
| Janssen Biotech, Inc. | 17 | $211 |
| Lilly USA, LLC | 14 | $101 |
| Eli Lilly and Company | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Corcept Therapeutics | 2 | $48 |
| GENZYME CORPORATION | 2 | $48 |
| Tandem Diabetes Care, Inc. | 3 | $32 |
| Averitas Pharma Inc. | 1 | $25 |
Products named: ADBRY, TREMFYA, ANZUPGO, TALTZ, GLASSIA, Korlym, DUPIXENT, ILUMYA.
Industry payments across AR — which companies pay providers there.
